A Phase I Study of LY3471851 in Healthy Participants

NCT05565729 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3471851
DRUG: Placebo
DRUG: Levocetirizine

Sponsor

Nektar Therapeutics

Collaborators

[object Object]